137 related articles for article (PubMed ID: 16290986)
21. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
[TBL] [Abstract][Full Text] [Related]
22. Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial.
Singh M; Williams BA; Gersh BJ; McClelland RL; Ho KK; Willerson JT; Penny WF; Cutlip DE; Holmes DR
J Am Coll Cardiol; 2006 Jan; 47(1):34-9. PubMed ID: 16386661
[TBL] [Abstract][Full Text] [Related]
23. Low restenosis rate of the NIR coronary stent: results of the Danish multicenter stent study (DANSTENT)--a randomized trial comparing a first-generation stent with a second-generation stent.
Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Madsen JK; Kløvgaard L; Thuesen L; Villadsen A; van Weert AW; Reiber JH;
Am Heart J; 2003 Feb; 145(2):e5. PubMed ID: 12595860
[TBL] [Abstract][Full Text] [Related]
24. Provisional stenting for multivessel PCI.
Han B; Liu L; Aboud M; Nahir M; Hasin Y
Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
[TBL] [Abstract][Full Text] [Related]
25. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
[TBL] [Abstract][Full Text] [Related]
26. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
[TBL] [Abstract][Full Text] [Related]
27. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
[TBL] [Abstract][Full Text] [Related]
28. Acute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable angina.
Leibundgut G; Lee JH; Strauss BH; Segev A; Tsimikas S
J Thromb Thrombolysis; 2016 May; 41(4):569-80. PubMed ID: 26964999
[TBL] [Abstract][Full Text] [Related]
29. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
[TBL] [Abstract][Full Text] [Related]
31. Intracoronary 166Holmium brachytherapy combined with cutting balloon angioplasty for the treatment of in-stent restenosis.
Park S; Kang WC; Rhee JH; Ko YG; Choi D; Jang Y; Lee JD; Shim WH; Cho SY
Cardiovasc Radiat Med; 2003; 4(3):119-25. PubMed ID: 14984711
[TBL] [Abstract][Full Text] [Related]
32. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
33. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).
Spadaccio C; Patti G; De Marco F; Coccia R; Di Domenico F; Pollari F; Zanzonico R; Pettinari M; Lusini M; Di Sciascio G; Covino E; Chello M
Am J Cardiol; 2013 Jul; 112(1):21-6. PubMed ID: 23561587
[TBL] [Abstract][Full Text] [Related]
35. Restenosis in the coronary stent is an argument for the surgical myocardial revascularization.
Goleanu V; Tintoiu I; Iacob M; Pinte F; Gafencu M; Mocanu I; Mustaţă D; Droc I; Dumitraşcu G; Greere V; Neagoe G; Lazar O; Labont B; Teodorescu A; Ravescu M; Trandafir D
Rom J Intern Med; 2003; 41(3):227-35. PubMed ID: 15526506
[TBL] [Abstract][Full Text] [Related]
36. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients.
Shang QH; Xu H; Lu XY; Wen C; Shi DZ; Chen KJ
Chin J Integr Med; 2011 Sep; 17(9):669-74. PubMed ID: 21910067
[TBL] [Abstract][Full Text] [Related]
37. Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus.
Mazeika P; Prasad N; Bui S; Seidelin PH
Am Heart J; 2003 Jun; 145(6):1013-21. PubMed ID: 12796757
[TBL] [Abstract][Full Text] [Related]
38. [Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty].
Araki T; Kanaya H; Shimizu M; Mabuchi H; Kitayama M; Kanemitsu S; Takekoshi N;
J Cardiol; 2001 Aug; 38(2):55-60. PubMed ID: 11525110
[TBL] [Abstract][Full Text] [Related]
39. [Study on correlation of blood-stasis syndrome and its accompanied syndromes with pathological changes showed in coronary angiography and restenosis after percutaneous coronary intervention].
Xu H; Lu XY; Chen KJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jan; 27(1):8-13. PubMed ID: 17302055
[TBL] [Abstract][Full Text] [Related]
40. Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis. Angiographic and intravascular ultrasound findings of a randomized study.
Alfonso F; García P; Fleites H; Pimentel G; Sabaté M; Hernández R; Escaned J; Bañuelos C; Pérez-Vizcayno MJ; Moreno R; Macaya C
Am Heart J; 2005 Feb; 149(2):e1-8. PubMed ID: 15846250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
